Ryan Asay | Vice President of Corporate Affairs |
David Meek | Chief Executive Officer |
Charles Baum | President, Founder & Head of Research & Development |
Laurie Stelzer | Chief Financial Officer |
James Christensen | Chief Scientific Officer |
Ben Hickey | Chief Commercial Officer |
Alan Sandler | Chief Medical Officer |
Salveen Richter | Goldman Sachs |
Tyler Van Buren | Cowen |
Gena Wang | Barclays |
Jonathan Miller | Evercore ISI |
Michael Schmidt | Guggenheim |
Michael Ulz | Morgan Stanley |
Jason Gerberry | Bank of America |
Maury Raycroft | Jefferies |
Eric Joseph | JPMorgan |
Benjamin Burnett | Stifel |
Andrew Berens | SVB Securities |
Yigal Nochomovitz | Citigroup |
Silvan Tuerkcan | JMP Securities |
Jay Olson | Oppenheimer |
Swapnil Malekar | Piper Sandler |
Kalpit Patel | B. Riley Securities |
Good afternoon, and welcome to the Mirati Therapeutics Third Quarter 2022 Earnings Call. My name is Jenny, and I will be the operator for today's call. All lines have been placed on mute to prevent any background noise. After the conclusion of the speakers prepared remarks, there will be a question-and-answer session. [Operator Instructions]